This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a trifluoromethyl group and a tetrahydroisoquinoline core, makes it valuable for developing potential pharmaceuticals, particularly those targeting neurological disorders and cardiovascular diseases. The trifluoromethyl group enhances the compound's metabolic stability and bioavailability, which is crucial for drug efficacy. Researchers often employ it in the design and optimization of drug candidates, leveraging its unique chemical properties to improve binding affinity and selectivity towards specific biological targets. Additionally, its hydrochloride salt form ensures better solubility and handling during experimental processes.